Gyre Therapeutics (GYRE) Other Working Capital Changes (2017 - 2022)
Gyre Therapeutics (GYRE) posted quarterly Other Working Capital Changes of $461000.0 for Q4 2025, up 132.98% year-over-year from $197874.7 in Q4 2024, and up 295.34% quarter-over-quarter from -$236000.0 in Q3 2025.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Other Working Capital Changes (2017 - 2022) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Other Working Capital Changes for 8 consecutive years, with $461000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 132.98% year-over-year to $461000.0; the TTM figure through Dec 2025 stood at -$1.3 million (down 5926.09% YoY), while the FY2025 annual figure was -$47000.0, down 304.35% from the prior year.
- Other Working Capital Changes improved to $461000.0 in Q4 2025 per GYRE's latest filing, from -$236000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.5 million in Q1 2025 and bottomed at -$5.4 million in Q2 2025.
- Historically, Other Working Capital Changes has averaged -$17235.3 across 5 years, with a median of -$6000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 10713.33% in 2024 and fell as far as 479.55% in 2024.
- Gyre Therapeutics' Other Working Capital Changes stood at -$623000.0 in 2021, then jumped by 68.06% to -$199000.0 in 2022, then jumped by 440.2% to $677000.0 in 2023, then sank by 306.5% to -$1.4 million in 2024, then soared by 132.98% to $461000.0 in 2025.
- Business Quant data shows GYRE's Other Working Capital Changes at $461000.0 in Q4 2025, -$236000.0 in Q3 2025, and -$1.4 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Gyre Therapeutics | 691.38 Mn | 633.98 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | -230,000.00 |
| Mar 31, 2022 | -230,000.00 |
| Dec 31, 2021 | -623,000.00 |
| Dec 31, 2021 | -623,000.00 |
| Sep 30, 2021 | -1.19 Mn |
| Sep 30, 2021 | -1.19 Mn |
| Jun 30, 2021 | 706,000.00 |
| Jun 30, 2021 | 706,000.00 |
| Mar 31, 2021 | -651,000.00 |
| Mar 31, 2021 | -651,000.00 |
| Dec 31, 2020 | 1.22 Mn |
| Dec 31, 2020 | 1.22 Mn |
| Sep 30, 2020 | 434,000.00 |
| Sep 30, 2020 | 434,000.00 |
| Jun 30, 2020 | 330,000.00 |
| Jun 30, 2020 | 330,000.00 |
| Mar 31, 2020 | -15.00 Mn |
| Mar 31, 2020 | -15.00 Mn |
| Mar 31, 2018 | -6,000.00 |
| Mar 31, 2018 | -6,000.00 |